These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
576 related articles for article (PubMed ID: 26247733)
1. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse. Peng M; Ball-Kell SM; Tyner AL Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733 [TBL] [Abstract][Full Text] [Related]
2. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
3. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK. Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922 [TBL] [Abstract][Full Text] [Related]
4. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo. Lahlou H; Sanguin-Gendreau V; Frame MC; Muller WJ Breast Cancer Res; 2012 Feb; 14(1):R36. PubMed ID: 22373082 [TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models. Peng M; Ball-Kell SM; Franks RR; Xie H; Tyner AL Oncogenesis; 2013 Dec; 2(12):e81. PubMed ID: 24323291 [TBL] [Abstract][Full Text] [Related]
6. Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer. Provenzano PP; Inman DR; Eliceiri KW; Beggs HE; Keely PJ Am J Pathol; 2008 Nov; 173(5):1551-65. PubMed ID: 18845837 [TBL] [Abstract][Full Text] [Related]
7. Protein Tyrosine Kinase 6 Regulates UVB-Induced Signaling and Tumorigenesis in Mouse Skin. Chastkofsky MI; Bie W; Ball-Kell SM; He YY; Tyner AL J Invest Dermatol; 2015 Oct; 135(10):2492-2501. PubMed ID: 25938342 [TBL] [Abstract][Full Text] [Related]
8. Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane. Gierut J; Zheng Y; Bie W; Carroll RE; Ball-Kell S; Haegebarth A; Tyner AL Gastroenterology; 2011 Oct; 141(4):1371-80, 1380.e1-2. PubMed ID: 21741923 [TBL] [Abstract][Full Text] [Related]
9. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors. Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967 [TBL] [Abstract][Full Text] [Related]
10. Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression. Zhao Y; Kumbrink J; Lin BT; Bouton AH; Yang S; Toselli PA; Kirsch KH Carcinogenesis; 2013 Dec; 34(12):2880-90. PubMed ID: 23825155 [TBL] [Abstract][Full Text] [Related]
11. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997 [TBL] [Abstract][Full Text] [Related]
13. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676 [TBL] [Abstract][Full Text] [Related]
14. A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis. Dearth RK; Kuiatse I; Wang YF; Liao L; Hilsenbeck SG; Brown PH; Xu J; Lee AV BMC Cancer; 2011 Aug; 11():377. PubMed ID: 21867536 [TBL] [Abstract][Full Text] [Related]